LWM
RDY icon

Lenox Wealth Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Lenox Wealth Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-59,745
Closed -$449K – 499
2017
Q4 		$449K Buy
59,745
+7,465
+14% +$53.8K 0.14% 107
2017
Q3 		$373K Buy
52,280
+3,700
+8% +$26.6K 0.13% 112
2017
Q2 		$409K Buy
+48,580
New +$395K 0.17% 102

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Lenox Wealth Management's RDY Position: Q1 2018 in Review

Lenox Wealth Management sold out of Dr. Reddy's Laboratories (RDY) in Q1 2018, closing a stake of 59,745 shares — an estimated $449K sold.

Lenox Wealth Management first reported a position in RDY in Q2 2017 and held it in 3 quarters. The position peaked at $449K in Q4 2017. 121 funds tracked by Wall St. Rank hold RDY as of Q1 2018.

  • Lenox Wealth Management reported no remaining Dr. Reddy's Laboratories position as of Q1 2018 after selling out during the quarter.
  • Lenox Wealth Management sold 59,745 Dr. Reddy's Laboratories shares in Q1 2018, an estimated $449K.
  • Lenox Wealth Management first reported a position in Dr. Reddy's Laboratories in Q2 2017 and held it in 3 quarters.
  • Lenox Wealth Management's Dr. Reddy's Laboratories position peaked at $449K in Q4 2017.
  • 121 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2018.

Based on Lenox Wealth Management's 13F filing for Q1 2018, filed 26 Apr 2018.